Serum IFN-γ and TNF-α levels in pulmonary tuberculosis

F. Sahin, F. Atabey, H. Can, S. Öztürk, A. Poluman (Istanbul, Turkey)

Source: Annual Congress 2005 - Biological and treatment aspects of tuberculosis
Session: Biological and treatment aspects of tuberculosis
Session type: Poster Discussion
Number: 2913
Disease area: Respiratory infections

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
F. Sahin, F. Atabey, H. Can, S. Öztürk, A. Poluman (Istanbul, Turkey). Serum IFN-γ and TNF-α levels in pulmonary tuberculosis. Eur Respir J 2005; 26: Suppl. 49, 2913

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
High serum CA-125 level in active pulmonary tuberculosis
Source: Eur Respir J 2005; 26: Suppl. 49, 415s
Year: 2005

Comparison of serum CA-125 levels in pulmonary tuberculosis, pleural tuberculosis and treated active pulmonary tuberculosis patients
Source: Eur Respir J 2005; 26: Suppl. 49, 453s
Year: 2005

Usefulness of serum procalcitonin levels in pulmonary tuberculosis
Source: Eur Respir J 2011; 37: 371
Year: 2011



High serum periostin levels and the association with pulmonary tuberculosis
Source: International Congress 2018 – Diagnosis of tuberculosis
Year: 2018

Elevated serum adiponectin level in patients with mycobacterium avium-intracellulare complex pulmonary disease
Source: Annual Congress 2008 - Infectious lung diseases including tuberculosis
Year: 2008

Profile of plasma cortisol levels in patients with pulmonary tuberculosis
Source: Eur Respir J 2003; 22: Suppl. 45, 154s
Year: 2003

Serum procalcitonin concentrations in children with pulmonary tuberculosis, tuberculous infection and lober pneumonia
Source: Eur Respir J 2003; 22: Suppl. 45, 176s
Year: 2003

Hypercalcemia and low parathormone levels in active pulmonary tuberculosis
Source: Eur Respir J 2003; 22: Suppl. 45, 155s
Year: 2003

Evaluation of D-dimer levels in patients with active pulmonary tuberculosis and latent tuberculosis infection
Source: Eur Respir J 2006; 28: Suppl. 50, 164s
Year: 2006

Serum concentration of cytokines before and during treatment in patients with active tuberculosis
Source: Eur Respir J 2002; 20: Suppl. 38, 10s
Year: 2002

Serum level of vitamin D3 before and after treatment in pulmonary tuberculosis
Source: Annual Congress 2012 - Tuberculosis: clinical findings I
Year: 2012


Serum levels of chitotriosidase in pulmunary sarcoidosis
Source: Annual Congress 2008 - COPD and other environment-related lung diseases
Year: 2008

Neopterin levels differential diagnosis of active and inactive pulmonary tuberculosis
Source: Eur Respir J 2006; 28: Suppl. 50, 341s
Year: 2006

Evaluation of sICAM-1 as a serum marker for follow-up of pulmonary tuberculosis therapy
Source: Eur Respir J 2005; 26: Suppl. 49, 454s
Year: 2005

Serum lipid profile and iron content in serum and pulmonary tissue in experimental pulmonary emphysema
Source: Annual Congress 2011 - Recent developments in COPD
Year: 2011

Levels of IL-1β and TNFα production in patients with lung tuberculosis
Source: Eur Respir J 2002; 20: Suppl. 38, 315s
Year: 2002

Serum lipid profile and zinc content in sera and pulmonary tissue of rabbits with pulmonary emphysema
Source: Annual Congress 2009 - Mechanisms of lung injury: COPD, asthma and acute lung injury
Year: 2009

A comparative study on serum ADA levels in cavitary and non-cavitary pulmonary tuberculosis patients
Source: Eur Respir J 2003; 22: Suppl. 45, 160s
Year: 2003

Serum lipid levels in patients with bronchiectasis
Source: Annual Congress 2008 - Aetiology of respiratory infections: mycobacteria and fungi
Year: 2008

Comparison of the serum soluble IL-2 receptor levels in the differential diagnosis of pulmonary tuberculosis and lung cancer
Source: Eur Respir J 2001; 18: Suppl. 33, 475s
Year: 2001